CPG
PCVX icon

Cornerstone Planning Group’s Vaxcyte PCVX Stock Holding History

Cornerstone Planning Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56 Hold
1
– – ﹤0.01% 1853
2026
Q1 		$56 Hold
1
– – ﹤0.01% 1806
2025
Q4 		$51 Sell
1
-146
-99% -$6.53K ﹤0.01% 1688
2025
Q3 		$41.9K Buy
147
+146
+14,600% +$4.84K 0.01% 386
2025
Q2 		$34 Hold
1
– – ﹤0.01% 1507
2025
Q1 		$33 Hold
1
– – ﹤0.01% 1528
2024
Q4 		$91 Hold
1
– – ﹤0.01% 1355
2024
Q3 		$106 Hold
1
– – ﹤0.01% 1251
2024
Q2 		$73 Hold
1
– – ﹤0.01% 1214
2024
Q1 		$66 Hold
1
– – ﹤0.01% 1054
2023
Q4 		$63 Hold
1
– – ﹤0.01% 919
2023
Q3 		$51 Buy
+1
New +$49 ﹤0.01% 1141

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cornerstone Planning Group's PCVX Position: Q2 2026 in Review

Cornerstone Planning Group held its Vaxcyte (PCVX) position steady in Q2 2026 at 1 share worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

Cornerstone Planning Group first reported a position in PCVX in Q3 2023 and has held it in 12 quarters since. The position peaked at $41.9K in Q3 2025. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Cornerstone Planning Group held 1 share of Vaxcyte worth $56 as of Q2 2026.
  • Cornerstone Planning Group left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1853 holding.
  • Cornerstone Planning Group first reported a position in Vaxcyte in Q3 2023 and has held it in 12 quarters since.
  • Cornerstone Planning Group's Vaxcyte position peaked at $41.9K in Q3 2025.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.